LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 3709 | 3846 | 0.9645 | 0.9572 |
Hs 578T | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 658 | 3127 | 3846 | 0.8130 | 0.7744 |
Hs 578T | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 658 | 456 | 3846 | 0.1186 | -0.0634 |
Hs 578T | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 658 | 517 | 3846 | 0.1344 | -0.0443 |
Hs 578T | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 658 | 3681 | 3846 | 0.9572 | 0.9484 |
Hs 578T | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3682 | 3846 | 0.9573 | 0.9485 |
Hs 578T | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3992 | 3846 | 1.0381 | 1.0460 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3387 | 3846 | 0.8808 | 0.8562 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 2807 | 3846 | 0.7299 | 0.6742 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 833 | 3846 | 0.2166 | 0.0548 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 668 | 3846 | 0.1737 | 0.0031 |
Hs 578T | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 1103 | 3846 | 0.2870 | 0.1397 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 658 | 4046 | 3846 | 1.0520 | 1.0627 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3756 | 3846 | 0.9766 | 0.9717 |
Hs 578T | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 1285 | 3846 | 0.3343 | 0.1968 |
Hs 578T | R406 | 0.37 | uM | LJP6 | 72 | hr | 658 | 3181 | 3846 | 0.8272 | 0.7915 |
Hs 578T | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 658 | 2388 | 3846 | 0.6211 | 0.5428 |
Hs 578T | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 3769 | 3846 | 0.9801 | 0.9760 |
Hs 578T | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 658 | 925 | 3846 | 0.2405 | 0.0837 |
Hs 578T | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 658 | 805 | 3846 | 0.2094 | 0.0462 |
Hs 578T | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 658 | 2717 | 3846 | 0.7064 | 0.6458 |
Hs 578T | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 658 | 2752 | 3846 | 0.7156 | 0.6569 |
Hs 578T | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 658 | 3526 | 3846 | 0.9168 | 0.8996 |
Hs 578T | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 658 | 653 | 3846 | 0.1700 | -0.0014 |
Hs 578T | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3094 | 3846 | 0.8046 | 0.7643 |